Cash-rich Moderna to begin first AstraZeneca trial under collab deal
July 28,2016
AstraZeneca ($AZN) and partner Moderna Therapeutics are heading to the lab for the first time together with their experimental cardiometabolic drug AZD8601.
The much-hyped biotech--which had by the start of 2016 raised more than $1.2 billion in VC and pa
Read More
< 1 >